TY - JOUR
T1 - Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells
AU - Hara, Toshihiko
AU - Bansal, Aditya
AU - DeGrado, Timothy R.
N1 - Funding Information:
The authors thank Dr. Robert A. Harris for invaluable comments and suggestions. The authors appreciate the technical assistance provided by Shuyan Wang. This work was supported by the National Institutes of Health (CA108620 and HL-63371) and the Indiana Genomics Initiative of Indiana University, which is supported in part by the Lilly Endowment.
PY - 2006/11
Y1 - 2006/11
N2 - Introduction: Choline, acetate and glucose ([2-18F]fluoro-2-deoxyglucose, [18F]FDG) analogs are under investigation as positron emission tomography (PET) tracers for the imaging of prostate cancer; however, their response to tumor hypoxia has not been clarified. Methods: The uptake of [methyl-3H]choline, [1-14C]acetate and [18F]FDG was monitored in androgen-independent PC-3 cells and androgen-sensitive LNCaP cells under aerobic or anoxic conditions. The effect of androgen depletion was also examined. Results: PC-3 cells exhibited aerobic choline and acetate uptake five to six times higher than FDG uptake, whereas LNCaP cells showed choline uptake 2.2-fold higher than acetate uptake and 10-fold higher than FDG uptake. After 4 h of anoxia, PC-3 cells showed an 85% increase in FDG uptake, a 15% decrease in choline uptake and a 36% increase in acetate uptake, whereas LNCaP cells showed a 212% increase in FDG uptake, a 28% decrease in choline uptake and no change in acetate uptake. Androgen depletion resulted in a marked decrease in the uptake of all tracers in LNCaP cells but no changes in PC-3 cells. Conclusion: In aerobic conditions, both PC-3 and LNCaP cells exhibited an order of uptake preference as follows: choline>acetate>FDG. In hypoxic cells, the order is reversed, reflecting diverse biochemical responses to hypoxia. These findings may help to explain PET imaging findings of the diverse responses of these tracers in different stages and locations of prostate cancer. Androgen depletion markedly suppressed the uptake of all three tracers in LNCaP cells, which suggests the potential for underestimation of the disease state when PET imaging is performed subsequent to antiandrogen therapy.
AB - Introduction: Choline, acetate and glucose ([2-18F]fluoro-2-deoxyglucose, [18F]FDG) analogs are under investigation as positron emission tomography (PET) tracers for the imaging of prostate cancer; however, their response to tumor hypoxia has not been clarified. Methods: The uptake of [methyl-3H]choline, [1-14C]acetate and [18F]FDG was monitored in androgen-independent PC-3 cells and androgen-sensitive LNCaP cells under aerobic or anoxic conditions. The effect of androgen depletion was also examined. Results: PC-3 cells exhibited aerobic choline and acetate uptake five to six times higher than FDG uptake, whereas LNCaP cells showed choline uptake 2.2-fold higher than acetate uptake and 10-fold higher than FDG uptake. After 4 h of anoxia, PC-3 cells showed an 85% increase in FDG uptake, a 15% decrease in choline uptake and a 36% increase in acetate uptake, whereas LNCaP cells showed a 212% increase in FDG uptake, a 28% decrease in choline uptake and no change in acetate uptake. Androgen depletion resulted in a marked decrease in the uptake of all tracers in LNCaP cells but no changes in PC-3 cells. Conclusion: In aerobic conditions, both PC-3 and LNCaP cells exhibited an order of uptake preference as follows: choline>acetate>FDG. In hypoxic cells, the order is reversed, reflecting diverse biochemical responses to hypoxia. These findings may help to explain PET imaging findings of the diverse responses of these tracers in different stages and locations of prostate cancer. Androgen depletion markedly suppressed the uptake of all three tracers in LNCaP cells, which suggests the potential for underestimation of the disease state when PET imaging is performed subsequent to antiandrogen therapy.
KW - Acetate
KW - Choline
KW - FDG
KW - Hypoxia
KW - Prostate cancer
UR - http://www.scopus.com/inward/record.url?scp=33751246442&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33751246442&partnerID=8YFLogxK
U2 - 10.1016/j.nucmedbio.2006.08.002
DO - 10.1016/j.nucmedbio.2006.08.002
M3 - Article
C2 - 17127170
AN - SCOPUS:33751246442
SN - 0969-8051
VL - 33
SP - 977
EP - 984
JO - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
JF - International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
IS - 8
ER -